REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.00
Bid: 171.60
Ask: 172.00
Change: 1.00 (0.58%)
Spread: 0.40 (0.233%)
Open: 172.00
High: 172.00
Low: 170.00
Prev. Close: 171.00
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of EUR 15 Million Share Buyback Programme

21 Feb 2024 07:00

RNS Number : 8374D
C&C Group Plc
21 February 2024
 

C&C Group plc

Launch of ?15 Million Share Buyback Programme

 

Dublin, London 21 February 2024: C&C Group plc ('C&C' or the 'Group'), owners of the Tennent's, Magners and Bulmers Ireland brands, and Matthew Clark and Bibendum Wine, announces that it will commence a share buyback programme on 1 March 2024 to repurchase ordinary shares of the Group (the "Shares") up to a maximum aggregate consideration of ?15 million (the "Programme").

 

The Programme forms part of the Group's plan to return up to ?150 million to shareholders over the next three fiscal years as announced in October 2023 through a combination of dividends and share buybacks and follows the reinstatement of dividend payments last year. The Programme is underpinned by the Board's confidence in the medium-term outlook for the business and its strong cash generation capabilities. The Board also believes that the Programme represents the most effective use of capital in the current environment.

 

Details of the Programme

The Group has entered into an agreement with J&E Davy ("Davy") to act as principal to conduct the Programme and to repurchase Shares on the Group's behalf for a maximum aggregate consideration of up to ?15 million and to make trading decisions under the Programme in accordance with certain pre-set parameters. Under the terms of the agreement, Davy will make purchases of the Shares under the Programme independently of, and uninfluenced by, the Group.

 

The Programme will commence on 1 March 2024, and end no later than 30 June 2024, subject to market conditions. The purpose of the Programme is to reduce the share capital of the Company in line with this announcement. Under the terms of the Programme, the Shares will be repurchased on the London Stock Exchange and will be cancelled. The Programme will be conducted in accordance with:

 

(i) the Group's general authority to repurchase shares (which authorises the repurchase of up to 40,270,889 Shares, being approximately 10% of the issued share capital of the Group), as approved by shareholders at the Group's AGM held on 13 July 2023 (the "Authority"); and

 

(ii) the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052 (including as each of them forms part of retained EU law in the United Kingdom ("UK") from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the applicable laws and regulations of the UK Financial Conduct Authority.

 

The execution of the Programme may be augmented by the purchase of Shares by way of block trades effected by Davy as agent of the Group. The maximum number of Shares which can be repurchased by the Group under the Programme will be reduced by the corresponding number of Shares repurchased pursuant to any such block trades. Any Shares repurchased through block trades will also count towards the maximum consideration payable by the Group.

 

Details of any Shares repurchased under the Share Buyback Programme will be notified to a Regulatory Information Service by the Group following repurchase. Purchases may continue under the Programme during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information.

 

There is no guarantee that the Programme will be implemented in full or that any Shares will be bought back by the Group.

 

 

ENDS

 

 

Contacts

 

C&C Group plc Riona Heffernan, Group Finance & Investor Relations Director

Email: riona.heffernan@candcgroup.com

 

Investors, Analysts & Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Aline Oliveira

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 83 833 1644

Email: CandCGroup@fticonsulting.com

 

About C&C Group plc

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland. 

C&C Group's portfolio of owned/exclusive brands include: Bulmers, the leading Irish cider brand; Tennent's, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

 

C&C Group is a FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUROARSRUUUUR
Date   Source Headline
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update
26th Jan 20233:45 pmRNSHolding(s) in Company
17th Jan 20232:40 pmRNSDirector/PDMR Shareholding
13th Jan 20237:00 amBUSTrading Statement
16th Dec 20222:45 pmRNSDirector/PDMR Shareholding
15th Dec 20223:15 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amBUSStatement re Directorate Change and Board Committee Update
5th Dec 20224:30 pmRNSHolding(s) in Company
2nd Dec 20222:28 pmRNSDirector Declaration
30th Nov 20224:45 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSBlock listing Interim Review
21st Nov 202212:00 pmRNSDirector/PDMR Shareholding
18th Nov 20227:10 amRNSDirector Declaration
9th Nov 20229:15 amRNSHolding(s) in Company
14th Sep 20227:00 amBUSStatement re H1 pre-close Trading Statement
16th Aug 20222:15 pmRNSDirector/PDMR Shareholding
28th Jul 202211:00 amRNS2021 Long Term Incentive Plan (‘LTIP’) Awards
26th Jul 20223:15 pmRNSDirector/PDMR Shareholding
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
18th Jul 20224:00 pmRNSHolding(s) in Company
15th Jul 20225:05 pmRNSDirector/PDMR Shareholding
7th Jul 20222:30 pmRNSResult of AGM
7th Jul 20227:00 amBUSAGM Statement
29th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20225:39 pmRNSHolding(s) in Company
15th Jun 20225:10 pmRNSDirector/PDMR Shareholding
10th Jun 20227:00 amRNSDirector/PDMR Shareholding
8th Jun 20228:30 amRNSAnnual Report and Notice of AGM
31st May 20224:45 pmRNSHolding(s) in Company
31st May 20227:00 amRNSBlock listing Interim Review
30th May 202210:00 amRNSHolding(s) in Company
24th May 20225:45 pmRNSHolding(s) in Company
17th May 20222:00 pmRNSDirector/PDMR Shareholding
17th May 20227:00 amBUSFinal Results
3rd May 20224:15 pmRNSDirector/PDMR Shareholding
16th Mar 20222:30 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amBUSTrading Statement
16th Feb 20223:45 pmRNSDirector/PDMR Shareholding
15th Feb 20222:45 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Jan 20227:00 amBUSTrading Statement
20th Dec 20213:00 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amBUSStatement re Notice of Capital Markets Day
3rd Dec 20219:35 amRNSHolding(s) in Company
1st Dec 202110:45 amRNSDirector Declaration
30th Nov 20217:00 amRNSBlock listing Interim Review
17th Nov 202111:45 amRNSDirector/PDMR Shareholding
29th Oct 20213:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.